Bempedoic acid/ezetimibe combination
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bempedoic acid/ezetimibe combination, covering 2022-03-03 to 2022-03-03. Get the full timeline:
Most recent: Clinical Trial Update: Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome Study [Phase 4]